Literature DB >> 8704223

Monoclonal gammopathy in patients with chronic hepatitis C virus infection.

P Andreone, A Gramenzi, C Cursaro, M Bernardi, A L Zignego.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8704223

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.

Authors:  Takumi Kawaguchi; Takafumi Yoshida; Masaru Harada; Takao Hisamoto; Yumiko Nagao; Tatsuya Ide; Eitaro Taniguchi; Hiroto Kumemura; Shinichiro Hanada; Michiko Maeyama; Shinji Baba; Hironori Koga; Ryukichi Kumashiro; Takato Ueno; Hisanobu Ogata; Akihiko Yoshimura; Michio Sata
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 2.  Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?

Authors:  Tawfik Khoury; Shmuel Chen; Tomer Adar; E Ollech Jacob; Meir Mizrahi
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

3.  Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.

Authors:  Mohamed Hassan; Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader
Journal:  World J Exp Med       Date:  2012-04-20

4.  Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association.

Authors:  Nauman A Jadoon; Mohammad A Shahzad; Rehan Yaqoob; Mansoor Hussain; Naseema Ali
Journal:  Virol J       Date:  2010-11-05       Impact factor: 4.099

Review 5.  Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options.

Authors:  Gabriele Pozzato; Cesare Mazzaro; Luigino Dal Maso; Endri Mauro; Francesca Zorat; Giulia Moratelli; Pietro Bulian; Diego Serraino; Valter Gattei
Journal:  World J Hepatol       Date:  2016-01-18

Review 6.  Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment.

Authors:  Antonino Carbone; Annunziata Gloghini
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 7.  HCV and lymphoproliferation.

Authors:  Anna Linda Zignego; Carlo Giannini; Laura Gragnani
Journal:  Clin Dev Immunol       Date:  2012-07-19

8.  Occult hepatitis C virus infection in patients with malignant lymphoproliferative disorders.

Authors:  Abeya A Lotfi; Asmaa E Mohamed; Nahela A Shalaby; Deena S Eissa; Ehab El-Dabaa; Ayman M Sallam; Mahmoud M Kamel; Hisham Abdelaziz; Amal M El-Afifi; Ahmed S Abdel-Moneim
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.